NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.50 +0.48 (+0.62%) GOLD FUTURES
2,395.00 +35.10 (+1.49%) DOW
39,847.79 +289.68 (+0.73%) Bitcoin GBP
51,267.37 +2,999.45 (+6.21%)
STTK Jun 2024 10.000 put
| Previous close | 1.6000 |
| Open | 1.6000 |
| Bid | 2.8000 |
| Ask | 3.3000 |
| Strike | 10.00 |
| Expiry date | 2024-06-21 |
| Day's range | 1.6000 - 1.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 25 |
GlobeNewswireShattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress
– Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and TP53m AML patients; successfully bridged responding TP53m AML patients to hematopoietic cell transplantation – – SL-172154 continued to demonstrate an acceptable safety profile in combination with AZA – – EHA poster presentation to include additional data from the next planned data cutoff in the second quarter of 2024 – AUSTIN, TX and DURHAM, NC, May 14, 2024 (GLOBE NEWS
ZacksWhat Makes Shattuck Labs (STTK) a New Buy Stock
Shattuck Labs (STTK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ZacksDoes Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 34.2% in Shattuck Labs (STTK). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
